CAMP
Camp4 Therapeutics CorpCompany with tickers: CAMP
CIK
1736730
CUSIP
13463J101
Shares Outstanding
51,925,800
13F Activity (30d)
45 filings
45 filers
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-01 | MacLean Michael F |
Director | Award | 56,000 |
| 2026-04-01 | Maricich Yuri |
Chief Medical Officer | Award | 215,000 |
| 2026-04-01 | Gold Kelly |
Chief Financial Officer | Award | 215,000 |
| 2026-04-01 | MacLean Michael F |
Director | Other | 0 |
| 2026-04-01 | Tardiff Daniel |
Chief Scientific Officer | Award | 170,000 |
| 2026-04-01 | Mandel-Brehm Josh |
Director, Chief Executive Officer | Award | 580,000 |
| 2025-12-11 | Gold Kelly |
Chief Financial Officer | Award | 190,000 |
| 2025-12-11 | Tardiff Daniel |
Chief Scientific Officer | Award | 145,500 |
| 2025-12-11 | Maricich Yuri |
Chief Medical Officer | Award | 190,000 |
| 2025-12-11 | Mandel-Brehm Josh |
Director, Chief Executive Officer | Award | 425,000 |
| 2025-10-01 | Tardiff Daniel |
Chief Scientific Officer | Other | 0 |
| 2025-10-01 | Tardiff Daniel |
Chief Scientific Officer | Other | 0 |
| 2025-10-01 | Tardiff Daniel |
Chief Scientific Officer | Other | 0 |
| 2025-10-01 | Tardiff Daniel |
Chief Scientific Officer | Other | 0 |
| 2025-09-11 | 5AM Partners VI, LLC |
10% Owner | Other | 302,770 |
| 2025-09-11 | Young Richard A |
Director | Buy | 15,151 |
| 2025-09-11 | Polaris Management Co. VII, L.L.C. |
10% Owner | Buy | 85,468 |
| 2025-09-11 | 5AM Partners VI, LLC |
10% Owner | Buy | 2,941,176 |
| 2025-09-11 | Mandel-Brehm Josh |
Director, Chief Executive Officer | Buy | 6,060 |
| 2025-09-11 | Nashat Amir |
Director | Other | 909,090 |
| 2025-09-11 | Schwab Andrew J. |
Director, 10% Owner | Award | 2,941,176 |
| 2025-09-11 | 5AM Partners VI, LLC |
10% Owner | Other | 2,625,145 |
| 2025-09-11 | Polaris Management Co. VII, L.L.C. |
10% Owner | Buy | 1,221,721 |
| 2025-09-11 | Nashat Amir |
Director | Buy | 85,468 |
| 2025-09-11 | Schwab Andrew J. |
Director, 10% Owner | Other | 302,770 |
| 2025-09-11 | Schwab Andrew J. |
Director, 10% Owner | Other | 2,625,145 |
| 2025-09-11 | Gold Kelly |
Chief Financial Officer | Buy | 6,060 |
| 2025-09-11 | Polaris Management Co. VII, L.L.C. |
10% Owner | Other | 909,090 |
| 2025-09-11 | Nashat Amir |
Director | Buy | 1,221,721 |
| 2025-09-11 | Maricich Yuri |
Chief Medical Officer | Buy | 6,060 |
| 2025-06-25 | Schwab Andrew J. |
Director, 10% Owner | Award | 9,000 |
| 2025-06-25 | Higgins Michael J |
Director | Award | 9,000 |
| 2025-06-25 | Ragan Paula |
Director | Award | 9,000 |
| 2025-06-25 | Thadhani Ravi I. |
Director | Award | 9,000 |
| 2025-06-25 | Nashat Amir |
Director | Award | 9,000 |
| 2025-06-25 | Boylan James P |
Director | Award | 9,000 |
| 2025-06-25 | Young Richard A |
Director | Award | 9,000 |
| 2025-06-25 | Holtzman Steven H |
Director | Award | 9,000 |
| 2025-04-01 | Gold Kelly |
Chief Financial Officer | Award | 80,000 |
| 2025-04-01 | Maricich Yuri |
Chief Medical Officer | Award | 80,000 |
| 2025-04-01 | Mandel-Brehm Josh |
Director, Chief Executive Officer | Award | 160,000 |
| 2025-04-01 | Bumcrot David |
Chief Scientific Officer | Award | 45,000 |
| 2025-03-17 | WILLIAMS DOUGLAS E |
Director | Other | 0 |
| 2025-03-17 | Stewart Murray |
Director | Other | 0 |
| 2025-03-17 | Stewart Murray |
Director | Award | 17,787 |
| 2025-03-17 | WILLIAMS DOUGLAS E |
Director | Award | 17,787 |
| 2024-10-15 | Nashat Amir |
Director | Other | 3,967,234 |
| 2024-10-15 | Nashat Amir |
Director | Other | 277,536 |
| 2024-10-15 | Northpond Ventures II GP, LLC |
10% Owner | Other | 1,003,193 |
| 2024-10-15 | Nashat Amir |
Director | Other | 980,829 |
Showing 1–50 of 162 transactions